Jiangsu Hengrui Medicine Co Ltd 2024 SR
The report highlights Jiangsu Hengrui Pharmaceuticals' sustainability progress in 2024, focusing on innovation, green development, and social responsibility. The company invested RMB 8.228 billion in R&D, with 19 Class 1 innovative drugs approved in China to date. Environmental achievements include three core manufacturing sites obtaining ISO 14001 certification and exceeding energy-saving targets by 140%. Socially, the company expanded its international footprint to over 40 countries and had 106 products included in China's National Reimbursement Drug List. The company also maintained an MSCI ESG rating of A for the second consecutive year.
Company: Jiangsu Hengrui Medicine Co Ltd
Sector: Health Care
Country: China
Year: 2024
Type: SR
Pages: 64
Jiangsu Hengrui Medicine Co Ltd
ESG Report
The report highlights Jiangsu Hengrui Pharmaceuticals' sustainability progress in 2024, focusing on innovation, green development, and social responsibility. The company invested RMB 8.228 billion in R&D, with 19 Class 1 innovative drugs approved in China to date. Environmental achievements include three core manufacturing sites obtaining ISO 14001 certification and exceeding energy-saving targets by 140%. Socially, the company expanded its international footprint to over 40 countries and had 106 products included in China's National Reimbursement Drug List. The company also maintained an MSCI ESG rating of A for the second consecutive year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Mar 27, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees